List of works - Susan P Colby-Germinario

A U1i RNA that Enhances HIV-1 RNA Splicing with an Elongated Recognition Domain Is an Optimal Candidate for Combination HIV-1 Gene Therapy

scientific article published on 18 October 2019

Antiretroviral protease inhibitors prevent l6 muscle cell fusion by reducing calpain activity

scientific article

Cenicriviroc blocks HIV entry but does not lead to redistribution of HIV into extracellular space like maraviroc

scientific article published on 2 November 2014

Complete inactivation of HIV-1 using photo-labeled non-nucleoside reverse transcriptase inhibitors ⬇️

scientific article published on October 19, 2010

Different Forms of Vanadate on Sugar Transport in Insulin Target and Nontarget Cells

scientific article

Effect of mutations at position E138 in HIV-1 reverse transcriptase and their interactions with the M184I mutation on defining patterns of resistance to nonnucleoside reverse transcriptase inhibitors rilpivirine and etravirine

scientific article published on 22 April 2013

Effects of the W153L substitution in HIV reverse transcriptase on viral replication and drug resistance to multiple categories of reverse transcriptase inhibitors

scientific article

Evaluation of Sofosbuvir (β-D-2'-deoxy-2'-α-fluoro-2'-β-C-methyluridine) as an inhibitor of Dengue virus replication

scientific article published on 24 July 2017

Exposure to entry inhibitors alters HIV infectiousness and sensitivity to broadly neutralizing monoclonal antibodies.

scientific article

HIV gp120 H375 is unique to HIV-1 subtype CRF01_AE and confers strong resistance to the entry inhibitor BMS-599793, a candidate microbicide drug.

scientific article published on 21 May 2012

HIV inactivation by cross-linking of photo-labeled anti-retroviral compounds with HIV reverse transcriptase

scientific article

Identification of a Pyridoxine-Derived Small-Molecule Inhibitor Targeting Dengue Virus RNA-Dependent RNA Polymerase

scientific article published on 16 November 2015

Identification of a dibenzocyclooctadiene lignan as a HIV-1 non-nucleoside reverse transcriptase inhibitor

scientific article published on February 2015

In vitro resistance profile of the candidate HIV-1 microbicide drug dapivirine

scientific article published on 28 November 2011

Maraviroc and Other HIV-1 Entry Inhibitors Exhibit a Class-Specific Redistribution Effect That Results in Increased Extracellular Viral Load ⬇️

scientific article published on May 21, 2012

Purification of Zika virus RNA-dependent RNA polymerase and its use to identify small-molecule Zika inhibitors

scientific article (publication date: 8 January 2017)

Role of the K101E substitution in HIV-1 reverse transcriptase in resistance to rilpivirine and other nonnucleoside reverse transcriptase inhibitors

scientific article published on 03 September 2013

Subtype-specific analysis of the K65R substitution in HIV-1 that confers hypersusceptibility to a novel nucleotide-competing reverse transcriptase inhibitor

scientific article published on 16 March 2015

Synergy against drug-resistant HIV-1 with the microbicide antiretrovirals, dapivirine and tenofovir, in combination ⬇️

scientific article published on August 24, 2011

The connection domain mutation N348I in HIV-1 reverse transcriptase enhances resistance to etravirine and rilpivirine but restricts the emergence of the E138K resistance mutation by diminishing viral replication capacity

scientific article

The dual CCR5 and CCR2 inhibitor cenicriviroc does not redistribute HIV into extracellular space: implications for plasma viral load and intracellular DNA decline.

scientific article

The effect of human immunodeficiency virus-1 protease inhibitors on the toxicity of a variety of cells

scientific article published on July 1, 2003

List of works by Susan P Colby-Germinario

A U1i RNA that Enhances HIV-1 RNA Splicing with an Elongated Recognition Domain Is an Optimal Candidate for Combination HIV-1 Gene Therapy

Antiretroviral protease inhibitors prevent l6 muscle cell fusion by reducing calpain activity

Cenicriviroc blocks HIV entry but does not lead to redistribution of HIV into extracellular space like maraviroc

Complete inactivation of HIV-1 using photo-labeled non-nucleoside reverse transcriptase inhibitors ⬇️

Different Forms of Vanadate on Sugar Transport in Insulin Target and Nontarget Cells

Effect of mutations at position E138 in HIV-1 reverse transcriptase and their interactions with the M184I mutation on defining patterns of resistance to nonnucleoside reverse transcriptase inhibitors rilpivirine and etravirine

Effects of the W153L substitution in HIV reverse transcriptase on viral replication and drug resistance to multiple categories of reverse transcriptase inhibitors

Evaluation of Sofosbuvir (β-D-2'-deoxy-2'-α-fluoro-2'-β-C-methyluridine) as an inhibitor of Dengue virus replication

Exposure to entry inhibitors alters HIV infectiousness and sensitivity to broadly neutralizing monoclonal antibodies.

HIV gp120 H375 is unique to HIV-1 subtype CRF01_AE and confers strong resistance to the entry inhibitor BMS-599793, a candidate microbicide drug.

HIV inactivation by cross-linking of photo-labeled anti-retroviral compounds with HIV reverse transcriptase

Identification of a Pyridoxine-Derived Small-Molecule Inhibitor Targeting Dengue Virus RNA-Dependent RNA Polymerase

Identification of a dibenzocyclooctadiene lignan as a HIV-1 non-nucleoside reverse transcriptase inhibitor

In vitro resistance profile of the candidate HIV-1 microbicide drug dapivirine

Maraviroc and Other HIV-1 Entry Inhibitors Exhibit a Class-Specific Redistribution Effect That Results in Increased Extracellular Viral Load ⬇️

Purification of Zika virus RNA-dependent RNA polymerase and its use to identify small-molecule Zika inhibitors

Role of the K101E substitution in HIV-1 reverse transcriptase in resistance to rilpivirine and other nonnucleoside reverse transcriptase inhibitors

Subtype-specific analysis of the K65R substitution in HIV-1 that confers hypersusceptibility to a novel nucleotide-competing reverse transcriptase inhibitor

Synergy against drug-resistant HIV-1 with the microbicide antiretrovirals, dapivirine and tenofovir, in combination ⬇️

The connection domain mutation N348I in HIV-1 reverse transcriptase enhances resistance to etravirine and rilpivirine but restricts the emergence of the E138K resistance mutation by diminishing viral replication capacity

The dual CCR5 and CCR2 inhibitor cenicriviroc does not redistribute HIV into extracellular space: implications for plasma viral load and intracellular DNA decline.

The effect of human immunodeficiency virus-1 protease inhibitors on the toxicity of a variety of cells